Cellular Technical Services Company (CTSC.OB), a publicly traded medical device company, announced that shareholders have approved a corporate name change, effective immediately. The company will now be called SafeStich Medical, but will still trade on the OTC Bulletin Board; however, the board of directs intends to apply for listing on the American Stock Exchange within the upcoming weeks.
The company’s short term goals include:
• FDA Registration of the company’s airway bite blocks product.
• Continued Product Development for obesity devices.
• Manufacturing of gastroplasty devices for clinical trials and engineering.
• Continued product development of Barrett’s Excision Device.
• Final product development of Smart dilator and application for FDA approval.
• Initial marketing and commercialization of standard and airway bite blocks and Smart dilator.
SafeStitch’s portfolio consists of a plethora of devices for obesity surgery and endoscopic surgery, as well as endoscopic devices for the diagnosis Barrett’s esophagus. The company plans to market a novel standard bite block, in addition to the first airway bite block, both utilized during endoscopic surgery. SmartStich has also begun pioneering the first Smart Dilator for esophageal surgery, a significant development for the company and patients alike.
Let us hear your thoughts below: